Monitoring the Session

HB 1987

bill repealing the trigger-law abortion ban

Died in committee

Verdict: No flags

No flagsInitial review
Rep. Rhetta Andrews BowersDHouse 113

Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.

Caption from analyzed text · version I.

Summary

Chapter 170A and the pre-1925-era ban go, plus several drug rules.

This bill repeals the state's trigger-law abortion ban in Chapter 170A and the old pre-1925-era abortion ban in the Revised Statutes, along with several rules on abortion-inducing drugs. It touches physicians, abortion facilities, hospitals and emergency clinics, and women seeking abortion, including those using abortion pills. Starting September 1, 2025, the main statewide bans are gone, pill providers may follow either the FDA label or 2013 ACOG dosage guidelines, and complication reporting by physicians is narrowed to abortions and complications handled at abortion facilities.

Labels

Labels: ZOMBIE BILL. Died 2 times: 88R HB 5087 (Died in committee) and this bill (Died in committee). Checked against 88R only.DO-OVER. Reworked text of a bill filed before that died: 88R HB 5087 (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.NEVER GOT A HEARING. Filed Jan 22, 2025 and referred to the House Public Health committee. No public hearing. The bill died.

Receipt

The receipt

89R-HB1987 · 2025-01-22

SOLD BY

ITEM

relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.

WHAT IT DOES

Chapter 170A and the pre-1925-era ban go, plus several drug rules.

This bill repeals the state's trigger-law abortion ban in Chapter 170A and the old pre-1925-era abortion ban in the Revised Statutes, along with several rules on abortion-inducing drugs. It touches physicians, abortion facilities, hospitals and emergency clinics, and women seeking abortion, including those using abortion pills. Starting September 1, 2025, the main statewide bans are gone, pill providers may follow either the FDA label or 2013 ACOG dosage guidelines, and complication reporting by physicians is narrowed to abortions and complications handled at abortion facilities.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Filed
  2. Read first time
  3. Referred to Public Health
FILED UNDER

No verified beat found.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Oct 29, 2024 to Oct 21, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Texas Sands PAC$12,000.00

Texas Sands PAC

$12,000.00

Cash
$12,000.00
Paid by others
$0.00
Total
$12,000.00

Also funds 121 other sitting lawmakers.

Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Jul 7, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987093, 101061918, 101070730.

Texas Trial Lawyers Association PAC$9,000.00

Texas Trial Lawyers Association PAC

$9,000.00

Cash
$9,000.00
Paid by others
$0.00
Total
$9,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Apr 16, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987093, 101011228, 101033763, 101061918.

House Democratic Campaign Committee$7,000.00

House Democratic Campaign Committee

$7,000.00

Cash
$7,000.00
Paid by others
$0.00
Total
$7,000.00

Also funds 9 other sitting lawmakers.

Derived recipient stock · Feb 3, 2026 to Sep 21, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Apr 30, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101061918.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Texas Sands PAC

$12,000.00

Cash
$12,000.00
Paid by others
$0.00
Total
$12,000.00

Also funds 121 other sitting lawmakers.

Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Jul 7, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987093, 101061918, 101070730.

×

Texas Trial Lawyers Association PAC

$9,000.00

Cash
$9,000.00
Paid by others
$0.00
Total
$9,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Apr 16, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987093, 101011228, 101033763, 101061918.

×

House Democratic Campaign Committee

$7,000.00

Cash
$7,000.00
Paid by others
$0.00
Total
$7,000.00

Also funds 9 other sitting lawmakers.

Derived recipient stock · Feb 3, 2026 to Sep 21, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Apr 30, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101061918.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

FILED BEFORE

Filed 2 times: 88R and 89R. Checked against 88R only.

88R HB 5087

by Rep. Bowers, same lead author · Died in committee · reworked

Introduced text

Last action, Mar 23, 2023: Referred to State Affairs

Relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.

Caption, 88R bill history

Sources

Texas House · Filed Jan 22, 2025

03/14/2025 H Referred to Public Health: Mar 14 2025 2:36PM

Texas Legislature Online · Introduced

Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.

House committee · Public Health · Final status: Died in committee

Companion

HB 1986 by Bowers (duplicate)

Subjects

Abortion

MEDICINE & PRESCRIPTION DRUGS

Text

The text as introduced · 846 words

By: Bowers
H.B. No. 1987

A BILL TO BE ENTITLED

AN ACT

relating to the regulation of abortion, including abortion

complication reporting and the repeal of certain laws prohibiting

abortion.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Sections 171.006(a) and (b), Health and Safety

Code, as added by Chapter 4 (H.B. 13), Acts of the 85th Legislature,

1st Called Session, 2017, are amended to read as follows:

(a) In this section, "abortion complication" means any

harmful event or adverse outcome with respect to a patient related

to an abortion that is performed on the patient and that is

diagnosed or treated by a health care practitioner or at a health

care facility and includes:

(1) shock;

(2) uterine perforation;

(3) cervical laceration;

(4) hemorrhage;

(5) aspiration or allergic response;

(6) infection;

(7) sepsis;

(8) death of the patient;

(9) incomplete abortion;

(10) damage to the uterus; or

(11) an infant born alive after the abortion

(b) The reporting requirements of this section apply only

to:

(1) a physician who:

(A) performs at an abortion facility an abortion

that results in an abortion complication diagnosed or treated by

that physician; or

(B) diagnoses or treats at an abortion facility

an abortion complication that is the result of an abortion

performed by another physician at the facility ; or

(2) a health care facility that is a hospital,

abortion facility, freestanding emergency medical care facility,

or health care facility that provides emergency medical care, as

defined by Section 773.003.

SECTION 2. Section 171.061, Health and Safety Code, is

amended by adding Subdivision (3) and amending Subdivision (8-a) to

read as follows:

(3) "Final printed label" means the informational

document approved by the United States Food and Drug Administration

for an abortion-inducing drug that:

(A) outlines the protocol authorized by that

agency and agreed to by the drug company applying for authorization

of the drug by that agency; and

(B) delineates the manner in which a drug is to be

used according to approval by that agency.

(8-a) "Provide" means, as used with regard to

abortion-inducing drugs, any act of giving, selling, dispensing,

administering, or otherwise providing or prescribing an

abortion-inducing drug.

SECTION 3. Section 171.063, Health and Safety Code, is

amended by amending Subsections (a), (c), and (e) and adding

Subsection (b) to read as follows:

(a) A person may not knowingly provide an abortion-inducing

drug to a pregnant woman for the purpose of inducing an abortion in

the pregnant woman or enabling another person to induce an abortion

in the pregnant woman unless:

(1) the person who provides the abortion-inducing drug

is a physician; and

(2) except as otherwise provided by Subsection (b),

the provision of the abortion-inducing drug satisfies the protocol

tested and authorized by the United States Food and Drug

Administration as outlined in the final printed label of the

abortion-inducing drug .

(b) A person may provide the abortion-inducing drug in the

dosage amount prescribed by the clinical management guidelines

defined by the American College of Obstetricians and Gynecologists

Practice Bulletin as those guidelines existed on January 1, 2013.

(c) Before the physician provides an abortion-inducing

drug, the physician must:

(1) examine the pregnant woman; and

(2) document, in the woman's medical record, the

gestational age and intrauterine location of the pregnancy

(d) A physician who provides the abortion-inducing drug, or

the physician's agent, must schedule a follow-up visit for the

woman to occur not later than the 14th day after the administration

or use of the abortion-inducing drug . At the follow-up visit, the

physician must:

(1) confirm that the woman's pregnancy is completely

terminated; and

(2) assess any continued blood loss.

SECTION 4. Section 171.206(b), Health and Safety Code, is

amended to read as follows:

(a) This subchapter may not be construed to:

(1) authorize the initiation of a cause of action

against or the prosecution of a woman on whom an abortion is

performed or induced or attempted to be performed or induced in

violation of this subchapter;

(2) wholly or partly repeal, either expressly or by

implication, any other statute that regulates or prohibits

abortion; or

(3) restrict a political subdivision from regulating

or prohibiting abortion in a manner that is at least as stringent as

the laws of this state.

SECTION 5. Section 171.207(b), Health and Safety Code, is

amended to read as follows:

(a) Subsection (a) may not be construed to:

(1) legalize the conduct prohibited by this

subchapter;

(2) limit in any way or affect the availability of a

remedy established by Section 171.208; or

(3) limit the enforceability of any other laws that

regulate or prohibit abortion.

SECTION 6. The following provisions are repealed:

(1) Chapter 170A, Health and Safety Code;

(2) Section 171.061(2-a), Health and Safety Code;

(3) Section 171.063(b-1), Health and Safety Code;

(4) Section 171.0631, Health and Safety Code;

(5) Section 171.0632, Health and Safety Code;

(6) Section 171.065, Health and Safety Code;

(7) Section 171.066, Health and Safety Code; and

(8) Chapter 6-1/2, Title 71, Revised Statutes.

SECTION 7. This Act takes effect September 1, 2025.